About Beta Bionics
Beta Bionics is a private company based in Irvine, California. It has reported $277,465,016 raised in four offerings on Form D since December 2017. Its chief executive is Sean Saint.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 28, 2023 | Sep 15, 2023 | $99,499,982of $101.7M target | 29 | $3.4M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 16, 2022 | Mar 2, 2022 | $57,049,776fully sold | 21 | $2.7M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 1, 2019 | Jul 22, 2019 | $63,360,000fully sold | 12 | $5.2M | EquityRule 506(b) | Form D ↗ |
| Dec 19, 2017 | Dec 27, 2017amended Oct 23, 2018 | $57,555,258target not set | 24 | $2.3M | Equity, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Total, four offerings | $277,465,016 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Beta Bionics's Form D filed Sep 15, 2023.
Earlier filings also listed Veena Rao (chief commercial officer, last listed Mar 2022), Michael Pereira (chief operating officer, last listed Mar 2022), Martha Aronson (interim chief executive officer and director, last listed Mar 2022), Marcie Cain (chief people officer, last listed Mar 2022), Jeffrey Hitchcock (director, last listed Mar 2022), Gibb Clarke (chief financial officer, last listed Mar 2022), Finny Kuruvilla (director, last listed Mar 2022) and Christy Jones (director, last listed Mar 2022).